Harvard Bioscience Inc. (HBIO) Rose 11.49% or 0.5 To Price $4.85 On Wednesday


Harvard Bioscience Inc. (HBIO) rose 11.49% or 0.5 to $4.85. It is close to 232525 shares traded, which is 183.92% compare to the average total volume 126424. The market cap of HBIO is $169.17 million. The year to date change is 31.82%. The 52 week price range is from $2.25 to $5.2. Price of HBIO have changed -4.40% during last week. It have changed -7.45% over last month, 31.82% over last 3 months, 35.94% over last 6 months and 64.15% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HBIO is 4.48. It is -7.63% below current price. The 200-day Moving Averages for HBIO is 3.43. It is -29.28% below current price. The 52-week High is 5.2. It is 7.22% from the current price. The 52-week Low is 2.25. It is -53.61% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HBIO is 1.83 on 2018-02-28. Short % to float is 0.83%. There are some statistics of HBIO. It is has market cap $169.17 million. The share outstanding is 34.88 million. The average volume is 126424. The revenue is 74.42M. It has 15.16M cash and 39.29M in debt. The gross profit is 34.43M. The percent of top 15 Institution holding is 46.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HBIO is -1.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HBIO is -0.89%.


Tags:

Share this post